STAT+: UnitedHealth conducting \u2018comprehensive review\u2019 of Medicare practices that are facing federal scrutiny, new CEO says
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
UnitedHealth Group\u2019s new CEO told investors that the company is reevaluating how it tallies Medicare Advantage patients\u2019 diagnoses for reimbursement purposes, an issue currently under investigation<\/a> by the Justice Department.\u00a0<\/p>\n Stephen Hemsley\u2019s remarks during the company\u2019s annual shareholder meeting on Monday signal a noteworthy shift: UnitedHealth is now publicly acknowledging potential issues with how it assesses the health of its Medicare Advantage members. <\/p>\n It\u2019s a stark contrast from Hemsley\u2019s predecessor, Andrew Witty, who pledged in April<\/a> to put the gas on \u201cengagement,\u201d or risk adjustment coding, and blamed the government\u2019s effort<\/a> to crack down on misused codes for causing the company\u2019s struggles. Witty stepped down the following month citing personal reasons, and the company pulled its profit outlook for the year.\u00a0<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n